2018-2023 Global Transdermal Drug Patches Consumption Market Report

July 2018 | 162 pages | ID: 2D3C989B4F6EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Transdermal Drug Patches market for 2018-2023.
A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.
Transdermal drug patches production has relatively high technology barrier and is technology intensive industry. Currently, there are many producing companies in the USA transdermal drug patches industry. The main market players are Noven, Mylan, Novartis and Johnson & Johnson. The production of transdermal drug patches will increase to 477482 K Units in 2016 from 340530 K Units in 2011 with average growth rate of 7.00%. USA transdermal drug patches capacity utilization rate remained at around 76.86% in 2015.
Transdermal drug patches mainly has some types, which include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch and oxybutynin transdermal patch. With medical effect of transdermal drug patches, the downstream application industries will need more transdermal drug patches products.
The major raw materials for transdermal drug patches are scopolamine, clonidine, nitroglycerin, isosorbide dinitrate, estradiol, norethindrone acetate and fentanyl, etc. Fluctuations in the price of the upstream product will impact on the production cost of transdermal drug patches, and then impact the price of transdermal drug patches. The production cost of transdermal drug patches is also an important factor which could impact the price of transdermal drug patches. The transdermal drug patches manufacturers are trying to produce many more types of transdermal drug patches for other different diseases.

Over the next five years, LPI(LP Information) projects that Transdermal Drug Patches will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Fentanyl Transdermal Patch
• Nicotine Transdermal Patch
• Buprenorphine Transdermal Patch
• Clonidine Transdermal Patch
• Oxybutynin Transdermal Patch
• Others

Segmentation by application:

• Used for Hypertension
• Used for Contraception
• Used for Analgesia
• Used for Smoking Cessation
• Used for Angina
• Used for Hormone Replacement

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Noven
• Mylan
• Novartis
• Johnson & Johnson
• Agile Therapeutics
• Teikoku Pharma USA
• Immune Pharmaceuticals
• Hercon Pharmaceuticals
• Pocono
• DURECT Corporation
• Xel Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Transdermal Drug Patches consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Transdermal Drug Patches market by identifying its various subsegments.
• Focuses on the key global Transdermal Drug Patches manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Transdermal Drug Patches with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Transdermal Drug Patches submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL TRANSDERMAL DRUG PATCHES CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Transdermal Drug Patches Consumption 2013-2023
  2.1.2 Transdermal Drug Patches Consumption CAGR by Region
2.2 Transdermal Drug Patches Segment by Type
  2.2.1 Fentanyl Transdermal Patch
  2.2.2 Nicotine Transdermal Patch
  2.2.3 Buprenorphine Transdermal Patch
  2.2.4 Clonidine Transdermal Patch
  2.2.5 Oxybutynin Transdermal Patch
  2.2.6 Others
2.3 Transdermal Drug Patches Consumption by Type
  2.3.1 Global Transdermal Drug Patches Consumption Market Share by Type (2013-2018)
  2.3.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Transdermal Drug Patches Sale Price by Type (2013-2018)
2.4 Transdermal Drug Patches Segment by Application
  2.4.1 Used for Hypertension
  2.4.2 Used for Contraception
  2.4.3 Used for Analgesia
  2.4.4 Used for Smoking Cessation
  2.4.5 Used for Angina
  2.4.6 Used for Hormone Replacement
2.5 Transdermal Drug Patches Consumption by Application
  2.5.1 Global Transdermal Drug Patches Consumption Market Share by Application (2013-2018)
  2.5.2 Global Transdermal Drug Patches Value and Market Share by Application (2013-2018)
  2.5.3 Global Transdermal Drug Patches Sale Price by Application (2013-2018)

3 GLOBAL TRANSDERMAL DRUG PATCHES BY PLAYERS

3.1 Global Transdermal Drug Patches Sales Market Share by Players
  3.1.1 Global Transdermal Drug Patches Sales by Players (2016-2018)
  3.1.2 Global Transdermal Drug Patches Sales Market Share by Players (2016-2018)
3.2 Global Transdermal Drug Patches Revenue Market Share by Players
  3.2.1 Global Transdermal Drug Patches Revenue by Players (2016-2018)
  3.2.2 Global Transdermal Drug Patches Revenue Market Share by Players (2016-2018)
3.3 Global Transdermal Drug Patches Sale Price by Players
3.4 Global Transdermal Drug Patches Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Transdermal Drug Patches Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Transdermal Drug Patches Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 TRANSDERMAL DRUG PATCHES BY REGIONS

4.1 Transdermal Drug Patches by Regions
  4.1.1 Global Transdermal Drug Patches Consumption by Regions
  4.1.2 Global Transdermal Drug Patches Value by Regions
4.2 Americas Transdermal Drug Patches Consumption Growth
4.3 APAC Transdermal Drug Patches Consumption Growth
4.4 Europe Transdermal Drug Patches Consumption Growth
4.5 Middle East & Africa Transdermal Drug Patches Consumption Growth

5 AMERICAS

5.1 Americas Transdermal Drug Patches Consumption by Countries
  5.1.1 Americas Transdermal Drug Patches Consumption by Countries (2013-2018)
  5.1.2 Americas Transdermal Drug Patches Value by Countries (2013-2018)
5.2 Americas Transdermal Drug Patches Consumption by Type
5.3 Americas Transdermal Drug Patches Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Transdermal Drug Patches Consumption by Countries
  6.1.1 APAC Transdermal Drug Patches Consumption by Countries (2013-2018)
  6.1.2 APAC Transdermal Drug Patches Value by Countries (2013-2018)
6.2 APAC Transdermal Drug Patches Consumption by Type
6.3 APAC Transdermal Drug Patches Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Transdermal Drug Patches by Countries
  7.1.1 Europe Transdermal Drug Patches Consumption by Countries (2013-2018)
  7.1.2 Europe Transdermal Drug Patches Value by Countries (2013-2018)
7.2 Europe Transdermal Drug Patches Consumption by Type
7.3 Europe Transdermal Drug Patches Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Transdermal Drug Patches by Countries
  8.1.1 Middle East & Africa Transdermal Drug Patches Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Transdermal Drug Patches Value by Countries (2013-2018)
8.2 Middle East & Africa Transdermal Drug Patches Consumption by Type
8.3 Middle East & Africa Transdermal Drug Patches Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Transdermal Drug Patches Distributors
10.3 Transdermal Drug Patches Customer

11 GLOBAL TRANSDERMAL DRUG PATCHES MARKET FORECAST

11.1 Global Transdermal Drug Patches Consumption Forecast (2018-2023)
11.2 Global Transdermal Drug Patches Forecast by Regions
  11.2.1 Global Transdermal Drug Patches Forecast by Regions (2018-2023)
  11.2.2 Global Transdermal Drug Patches Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Transdermal Drug Patches Forecast by Type
11.8 Global Transdermal Drug Patches Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Noven
  12.1.1 Company Details
  12.1.2 Transdermal Drug Patches Product Offered
  12.1.3 Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Noven News
12.2 Mylan
  12.2.1 Company Details
  12.2.2 Transdermal Drug Patches Product Offered
  12.2.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Mylan News
12.3 Novartis
  12.3.1 Company Details
  12.3.2 Transdermal Drug Patches Product Offered
  12.3.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Novartis News
12.4 Johnson & Johnson
  12.4.1 Company Details
  12.4.2 Transdermal Drug Patches Product Offered
  12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Johnson & Johnson News
12.5 Agile Therapeutics
  12.5.1 Company Details
  12.5.2 Transdermal Drug Patches Product Offered
  12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Agile Therapeutics News
12.6 Teikoku Pharma USA
  12.6.1 Company Details
  12.6.2 Transdermal Drug Patches Product Offered
  12.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Teikoku Pharma USA News
12.7 Immune Pharmaceuticals
  12.7.1 Company Details
  12.7.2 Transdermal Drug Patches Product Offered
  12.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Immune Pharmaceuticals News
12.8 Hercon Pharmaceuticals
  12.8.1 Company Details
  12.8.2 Transdermal Drug Patches Product Offered
  12.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Hercon Pharmaceuticals News
12.9 Pocono
  12.9.1 Company Details
  12.9.2 Transdermal Drug Patches Product Offered
  12.9.3 Pocono Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Pocono News
12.10 DURECT Corporation
  12.10.1 Company Details
  12.10.2 Transdermal Drug Patches Product Offered
  12.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 DURECT Corporation News
12.11 Xel Pharmaceuticals

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Transdermal Drug Patches
Table Product Specifications of Transdermal Drug Patches
Figure Transdermal Drug Patches Report Years Considered
Figure Market Research Methodology
Figure Global Transdermal Drug Patches Consumption Growth Rate 2013-2023 (K Units)
Figure Global Transdermal Drug Patches Value Growth Rate 2013-2023 ($ Millions)
Table Transdermal Drug Patches Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Fentanyl Transdermal Patch
Table Major Players of Fentanyl Transdermal Patch
Figure Product Picture of Nicotine Transdermal Patch
Table Major Players of Nicotine Transdermal Patch
Figure Product Picture of Buprenorphine Transdermal Patch
Table Major Players of Buprenorphine Transdermal Patch
Figure Product Picture of Clonidine Transdermal Patch
Table Major Players of Clonidine Transdermal Patch
Figure Product Picture of Oxybutynin Transdermal Patch
Table Major Players of Oxybutynin Transdermal Patch
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Transdermal Drug Patches Consumption Market Share by Type (2013-2018)
Figure Global Transdermal Drug Patches Consumption Market Share by Type (2013-2018)
Table Global Transdermal Drug Patches Revenue by Type (2013-2018) ($ million)
Table Global Transdermal Drug Patches Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Transdermal Drug Patches Value Market Share by Type (2013-2018)
Table Global Transdermal Drug Patches Sale Price by Type (2013-2018)
Figure Transdermal Drug Patches Consumed in Used for Hypertension
Figure Global Transdermal Drug Patches Market: Used for Hypertension (2013-2018) (K Units)
Figure Global Transdermal Drug Patches Market: Used for Hypertension (2013-2018) ($ Millions)
Figure Global Used for Hypertension YoY Growth ($ Millions)
Figure Transdermal Drug Patches Consumed in Used for Contraception
Figure Global Transdermal Drug Patches Market: Used for Contraception (2013-2018) (K Units)
Figure Global Transdermal Drug Patches Market: Used for Contraception (2013-2018) ($ Millions)
Figure Global Used for Contraception YoY Growth ($ Millions)
Figure Transdermal Drug Patches Consumed in Used for Analgesia
Figure Global Transdermal Drug Patches Market: Used for Analgesia (2013-2018) (K Units)
Figure Global Transdermal Drug Patches Market: Used for Analgesia (2013-2018) ($ Millions)
Figure Global Used for Analgesia YoY Growth ($ Millions)
Figure Transdermal Drug Patches Consumed in Used for Smoking Cessation
Figure Global Transdermal Drug Patches Market: Used for Smoking Cessation (2013-2018) (K Units)
Figure Global Transdermal Drug Patches Market: Used for Smoking Cessation (2013-2018) ($ Millions)
Figure Global Used for Smoking Cessation YoY Growth ($ Millions)
Figure Transdermal Drug Patches Consumed in Used for Angina
Figure Global Transdermal Drug Patches Market: Used for Angina (2013-2018) (K Units)
Figure Global Transdermal Drug Patches Market: Used for Angina (2013-2018) ($ Millions)
Figure Global Used for Angina YoY Growth ($ Millions)
Figure Transdermal Drug Patches Consumed in Used for Hormone Replacement
Table Global Consumption Sales by Application (2013-2018)
Table Global Transdermal Drug Patches Consumption Market Share by Application (2013-2018)
Figure Global Transdermal Drug Patches Consumption Market Share by Application (2013-2018)
Table Global Transdermal Drug Patches Value by Application (2013-2018)
Table Global Transdermal Drug Patches Value Market Share by Application (2013-2018)
Figure Global Transdermal Drug Patches Value Market Share by Application (2013-2018)
Table Global Transdermal Drug Patches Sale Price by Application (2013-2018)
Table Global Transdermal Drug Patches Sales by Players (2016-2018) (K Units)
Table Global Transdermal Drug Patches Sales Market Share by Players (2016-2018)
Figure Global Transdermal Drug Patches Sales Market Share by Players in 2016
Figure Global Transdermal Drug Patches Sales Market Share by Players in 2017
Table Global Transdermal Drug Patches Revenue by Players (2016-2018) ($ Millions)
Table Global Transdermal Drug Patches Revenue Market Share by Players (2016-2018)
Figure Global Transdermal Drug Patches Revenue Market Share by Players in 2016
Figure Global Transdermal Drug Patches Revenue Market Share by Players in 2017
Table Global Transdermal Drug Patches Sale Price by Players (2016-2018)
Figure Global Transdermal Drug Patches Sale Price by Players in 2017
Table Global Transdermal Drug Patches Manufacturing Base Distribution and Sales Area by Players
Table Players Transdermal Drug Patches Products Offered
Table Transdermal Drug Patches Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Transdermal Drug Patches Consumption by Regions 2013-2018 (K Units)
Table Global Transdermal Drug Patches Consumption Market Share by Regions 2013-2018
Figure Global Transdermal Drug Patches Consumption Market Share by Regions 2013-2018
Table Global Transdermal Drug Patches Value by Regions 2013-2018 ($ Millions)
Table Global Transdermal Drug Patches Value Market Share by Regions 2013-2018
Figure Global Transdermal Drug Patches Value Market Share by Regions 2013-2018
Figure Americas Transdermal Drug Patches Consumption 2013-2018 (K Units)
Figure Americas Transdermal Drug Patches Value 2013-2018 ($ Millions)
Figure APAC Transdermal Drug Patches Consumption 2013-2018 (K Units)
Figure APAC Transdermal Drug Patches Value 2013-2018 ($ Millions)
Figure Europe Transdermal Drug Patches Consumption 2013-2018 (K Units)
Figure Europe Transdermal Drug Patches Value 2013-2018 ($ Millions)
Figure Middle East & Africa Transdermal Drug Patches Consumption 2013-2018 (K Units)
Figure Middle East & Africa Transdermal Drug Patches Value 2013-2018 ($ Millions)
Table Americas Transdermal Drug Patches Consumption by Countries (2013-2018) (K Units)
Table Americas Transdermal Drug Patches Consumption Market Share by Countries (2013-2018)
Figure Americas Transdermal Drug Patches Consumption Market Share by Countries in 2017
Table Americas Transdermal Drug Patches Value by Countries (2013-2018) ($ Millions)
Table Americas Transdermal Drug Patches Value Market Share by Countries (2013-2018)
Figure Americas Transdermal Drug Patches Value Market Share by Countries in 2017
Table Americas Transdermal Drug Patches Consumption by Type (2013-2018) (K Units)
Table Americas Transdermal Drug Patches Consumption Market Share by Type (2013-2018)
Figure Americas Transdermal Drug Patches Consumption Market Share by Type in 2017
Table Americas Transdermal Drug Patches Consumption by Application (2013-2018) (K Units)
Table Americas Transdermal Drug Patches Consumption Market Share by Application (2013-2018)
Figure Americas Transdermal Drug Patches Consumption Market Share by Application in 2017
Figure United States Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure United States Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Canada Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Canada Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Mexico Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Mexico Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Table APAC Transdermal Drug Patches Consumption by Countries (2013-2018) (K Units)
Table APAC Transdermal Drug Patches Consumption Market Share by Countries (2013-2018)
Figure APAC Transdermal Drug Patches Consumption Market Share by Countries in 2017
Table APAC Transdermal Drug Patches Value by Countries (2013-2018) ($ Millions)
Table APAC Transdermal Drug Patches Value Market Share by Countries (2013-2018)
Figure APAC Transdermal Drug Patches Value Market Share by Countries in 2017
Table APAC Transdermal Drug Patches Consumption by Type (2013-2018) (K Units)
Table APAC Transdermal Drug Patches Consumption Market Share by Type (2013-2018)
Figure APAC Transdermal Drug Patches Consumption Market Share by Type in 2017
Table APAC Transdermal Drug Patches Consumption by Application (2013-2018) (K Units)
Table APAC Transdermal Drug Patches Consumption Market Share by Application (2013-2018)
Figure APAC Transdermal Drug Patches Consumption Market Share by Application in 2017
Figure China Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure China Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Japan Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Japan Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Korea Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Korea Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure India Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure India Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Australia Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Australia Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Table Europe Transdermal Drug Patches Consumption by Countries (2013-2018) (K Units)
Table Europe Transdermal Drug Patches Consumption Market Share by Countries (2013-2018)
Figure Europe Transdermal Drug Patches Consumption Market Share by Countries in 2017
Table Europe Transdermal Drug Patches Value by Countries (2013-2018) ($ Millions)
Table Europe Transdermal Drug Patches Value Market Share by Countries (2013-2018)
Figure Europe Transdermal Drug Patches Value Market Share by Countries in 2017
Table Europe Transdermal Drug Patches Consumption by Type (2013-2018) (K Units)
Table Europe Transdermal Drug Patches Consumption Market Share by Type (2013-2018)
Figure Europe Transdermal Drug Patches Consumption Market Share by Type in 2017
Table Europe Transdermal Drug Patches Consumption by Application (2013-2018) (K Units)
Table Europe Transdermal Drug Patches Consumption Market Share by Application (2013-2018)
Figure Europe Transdermal Drug Patches Consumption Market Share by Application in 2017
Figure Germany Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Germany Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure France Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure France Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure UK Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure UK Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Italy Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Italy Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Russia Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Russia Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Spain Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Spain Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Transdermal Drug Patches Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Transdermal Drug Patches Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Transdermal Drug Patches Consumption Market Share by Countries in 2017
Table Middle East & Africa Transdermal Drug Patches Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Transdermal Drug Patches Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Transdermal Drug Patches Value Market Share by Countries in 2017
Table Middle East & Africa Transdermal Drug Patches Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Transdermal Drug Patches Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Transdermal Drug Patches Consumption Market Share by Type in 2017
Table Middle East & Africa Transdermal Drug Patches Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Transdermal Drug Patches Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Transdermal Drug Patches Consumption Market Share by Application in 2017
Figure Egypt Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Egypt Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure South Africa Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure South Africa Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Israel Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Israel Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure Turkey Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure Turkey Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Transdermal Drug Patches Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Transdermal Drug Patches Value Growth 2013-2018 ($ Millions)
Table Transdermal Drug Patches Distributors List
Table Transdermal Drug Patches Customer List
Figure Global Transdermal Drug Patches Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Transdermal Drug Patches Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Transdermal Drug Patches Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Transdermal Drug Patches Consumption Market Forecast by Regions
Table Global Transdermal Drug Patches Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Transdermal Drug Patches Value Market Share Forecast by Regions
Figure Americas Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Americas Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure APAC Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure APAC Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Europe Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Europe Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Middle East & Africa Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Middle East & Africa Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure United States Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure United States Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Canada Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Canada Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Mexico Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Mexico Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Brazil Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Brazil Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure China Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure China Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Japan Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Japan Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Korea Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Korea Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Southeast Asia Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Southeast Asia Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure India Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure India Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Australia Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Australia Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Germany Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Germany Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure France Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure France Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure UK Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure UK Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Italy Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Italy Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Russia Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Russia Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Spain Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Spain Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Egypt Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Egypt Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure South Africa Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure South Africa Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Israel Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Israel Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure Turkey Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure Turkey Transdermal Drug Patches Value 2018-2023 ($ Millions)
Figure GCC Countries Transdermal Drug Patches Consumption 2018-2023 (K Units)
Figure GCC Countries Transdermal Drug Patches Value 2018-2023 ($ Millions)
Table Global Transdermal Drug Patches Consumption Forecast by Type (2018-2023) (K Units)
Table Global Transdermal Drug Patches Consumption Market Share Forecast by Type (2018-2023)
Table Global Transdermal Drug Patches Value Forecast by Type (2018-2023) ($ Millions)
Table Global Transdermal Drug Patches Value Market Share Forecast by Type (2018-2023)
Table Global Transdermal Drug Patches Consumption Forecast by Application (2018-2023) (K Units)
Table Global Transdermal Drug Patches Consumption Market Share Forecast by Application (2018-2023)
Table Global Transdermal Drug Patches Value Forecast by Application (2018-2023) ($ Millions)
Table Global Transdermal Drug Patches Value Market Share Forecast by Application (2018-2023)
Table Noven Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Noven Transdermal Drug Patches Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Transdermal Drug Patches Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Transdermal Drug Patches Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Transdermal Drug Patches Market Share (2016-2018)
Table Agile Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Agile Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Agile Therapeutics Transdermal Drug Patches Market Share (2016-2018)
Table Teikoku Pharma USA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teikoku Pharma USA Transdermal Drug Patches Market Share (2016-2018)
Table Immune Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Immune Pharmaceuticals Transdermal Drug Patches Market Share (2016-2018)
Table Hercon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hercon Pharmaceuticals Transdermal Drug Patches Market Share (2016-2018)
Table Pocono Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pocono Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pocono Transdermal Drug Patches Market Share (2016-2018)
Table DURECT Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table DURECT Corporation Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2016-2018)
Figure DURECT Corporation Transdermal Drug Patches Market Share (2016-2018)
Table Xel Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors